Nutex Health (NUTX) Other financing activities (2012 - 2024)

Nutex Health has reported Other financing activities for 10 years, with the latest figure at $1.6 million in Q4 2024.

• Quarterly Other financing activities rose 342.01% year-over-year to $1.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 57.65% YoY) and the FY2024 annual result came in at $2.4 million, changed N/A from the prior year.
• Other financing activities rose to $1.6 million in Q4 2024 per NUTX's latest filing, from $800000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $21.8 million in Q4 2021 and troughed at -$11.0 million in Q3 2021.
• A 5-year average of $2.2 million and a median of $524970.0 in 2022 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2020 and 2021: Other financing activities jumped 97587.27% in 2020, then plunged 2691173.17% in 2021.
• Over 5 years, Other financing activities stood at $10.0 million in 2020, then soared by 116.96% to $21.8 million in 2021, then plunged by 115.97% to -$3.5 million in 2022, then jumped by 81.3% to -$649550.0 in 2023, then surged by 342.01% to $1.6 million in 2024.
• According to Business Quant data, Other financing activities over the past three periods registered $1.6 million, $800000.0, and -$1.2 million for Q4 2024, Q3 2024, and Q2 2024 respectively.